Lisdexamfetamine Dimesylate 60505-4741
Product NDC
60505-4741- Manufacturer
- Apotex Corp.
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- November 9, 2023
- Listing Expires
- December 31, 2027
- Application
- ANDA216944
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lisdexamfetamine Dimesylate | 30 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Packaging Options(1)
100 CAPSULE in 1 BOTTLE (60505-4741-1)